The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Computational drug discovery and design embodies the integration of advanced computational methods, machine learning, and cheminformatics to streamline the identification and optimisation of ...

Discover how amyloid proteins help form long-term memories according to new research from the Stowers Institute.

Nvidia and Eli Lilly and Co. are partnering to create an artificial intelligence lab in the San Francisco Bay Area to revolutionize drug discovery, investing up to $1 billion over the next five years.

Despite significant strides made in AI, particularly with breakthroughs like AlphaFold, the real-world application of these technologies in drug discovery is hindered by various institutional ...

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...

AI in drug discovery offers key market opportunities by enhancing drug development efficiency, reducing costs, and improving success rates. It supports personalized medicine, facilitating custom ...

Voyager Technologies recently announced a new contract with Space LiinTech to manage a drug-discovery payload to the International Space Station, providing mission integration, payload configuration ...

Veeva Systems markets a suite of software services geared toward the biopharmaceutical industry. A wholly owned customer relationship management service is gaining steam for Veeva Systems. With access ...